| Literature DB >> 21332991 |
Liuzhen Ye1, Leonid Kalichman, Alicia Spittle, Fiona Dobson, Kim Bennell.
Abstract
INTRODUCTION: Hand osteoarthritis (OA) is associated with pain, reduced grip strength, loss of range of motion and joint stiffness leading to impaired hand function and difficulty with daily activities. The effectiveness of different rehabilitation interventions on specific treatment goals has not yet been fully explored. The objective of this systematic review is to provide evidence based knowledge on the treatment effects of different rehabilitation interventions for specific treatment goals for hand OA.Entities:
Mesh:
Year: 2011 PMID: 21332991 PMCID: PMC3241372 DOI: 10.1186/ar3254
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Figure 1Flow diagram of the results of the study selection procedure, which is in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. OA, osteoarthritis; RCT, randomized controlled trial.
Study design and participant characteristics
| Reference | Study design | LOE | Total, n | Gender | Age, years | Diagnosis of hand OA | CMC joint OA | IP joint OA | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| M, n | F, n | Mean (SD) | |||||||||
| Intervention | Control | Clinical | Radiology | ||||||||
| Rannou, | RCT | 1b | 112 | 11 | 101 | 63 (8) | 64 (8) | Yes | Yes | Yes | Yes |
| Basford, | RCT | 1b | 81 | NS | NS | 57 (NS) | 63 (NS) | Yes | No | Yes | Yes |
| Brosseau, | RCT | 1b | 88 | 19 | 69 | 64 (10) | 65 (10) | Yes | Yes | Yes | Yes |
| Stange-Rezende, | Crossover | 2b | 45 | 3 | 42 | 60 (8) | 60 (8) | Yes | No | Yes | Yes |
| Favaro, | Quasi-RCT | 2b | 48 | 5 | 43 | 56 (6) | 60 (8) | Yes | Yes | NS | NS |
| Stamm, | RCT | 2b | 40 | 5 | 35 | 61 (8) | 60 (8) | Yes | No | Yes | Yes |
| Lefler and Armstrong [ | RCT | 2b Yes | 19 | 2 | 17 | 82 (10) | 82 (8) | NS | NS | NS | NS |
| Rogers and Wilder [ | Crossover | 2b | 76 | 11 | 65 | 75 (7) | 75 (7) | Yes | Yes | NS | NS |
| Field, | RCT | 2b Yes | 22 | 1 | 21 | NS | NS | NS | NS | NS | NS |
| Dickens and Lewith [ | RCT | 1b | 13 | 5 | 7 | 59 (9) | 59.2 (6) | Yes | Yes | Yes | No |
CMC, carpometacarpal; F, female; IP, interphalageal; LOE, level of evidence (Oxford); M, male; n, number; NS, not stated; OA, osteoarthritis; RCT, randomized controlled trial; SD, standard deviation.
Description of study interventions and outcome measures
| Study | Intervention | Control intervention | Intervention duration | Post-treatment measurements | Outcome measures |
|---|---|---|---|---|---|
| Rannou, | Use of splint at night only | Usual care based on physician's discretion | 1 year | 1 month (use of splint) Immediate | VAS (previous 48 hours) VAS during pinch CHFS Pinch strength Kapandji index |
| Basford, | Laser (15 seconds × 4 points) × 3 sessions/week | Sham laser (15 seconds × 4 points) × 3 sessions/week | 3 weeks | Immediate | Joint tenderness of thumb CMC, MCP, and IP and of other joints (0-5) Grasp, lateral pinch, and 3-finger chuck pinch strength Thumb CMC planar and palmar abduction, thumb MCP extension and flexion, and thumb IP extension and flexion |
| Brosseau, | Laser (1 second × 74 points) × 20 minutes/session × 3 sessions/week | Sham laser (1 second × 74 points) × 20 minutes/session × 3 sessions/week | 6 weeks | Immediate 6 weeks 12 weeks 24 weeks | AUSCAN VAS (data not available) Lateral pinch and 3-finger chuck pinch strength CMC flexion and opposition, DIP flexion, MCP flexion, and PIP flexion ROM |
| Stange-Rezende, | Room with heated tiled stove (≥3 hours × 3 sessions/week) + customary treatment (as for control) | Customary treatment (NSAIDs, analgesics, home exercises, physiotherapy) | 3 weeks | Immediate | VAS (general pain; in hands and global hand function) AUSCAN Grip strength |
| Favaro, | Infrared radiation (20 minutes/sessions × 10 sessions) | Sham infrared radiation (not reported) | Not reported | Not reported | Grip strength |
| Stamm, | Joint protection program - written instructions plus home exercise program (7 ROM exercises × 10 times daily) | Education about OA (20-minute session) plus use of non-slip matting to open jars | 3 months | Immediate | Self-reported global hand function - HAQ Grip strength |
| Lefler and Armstrong [ | Strengthening exercise program × 3 sessions/week | No treatment | 6 weeks | Immediate | Pain (0-6) Grip, palmar, 2nd-5th digit, and lateral pinch strength Finger joint ROM |
| Rogers and Wilder [ | Exercise program (6 ROM exercises and 3 strengthening exercises) (10 to 15 minutes daily) | Sham hand cream (cream was applied once daily using gentle technique) | 16 weeks | Immediate | AUSCAN Maximal right grip strength and other grip and pinch strength |
| Field, | Massage on wrist/hand (once/week) + daily home self-massage | No treatment | 4 weeks | Immediate | VAS anchored with 5 faces (VITAS) Perceived grip strength |
| Dickens and Lewith [ | Acupuncture (6 sessions over 2 weeks) | Mock transcutaneous electrical nerve stimulation (6 sessions over 2 weeks) | 2 weeks | Immediate 2 weeks | VAS in general, joint tenderness Functional score Pinch strength |
ROM refers to active range of motion of carpometacarpal (CMC), metacarpophalangeal (MCP), and interphalangeal (IP) of the thumb and MCP, distal interphalangeal (DIP), and proximal interphalangeal (PIP) joint movements of the 2nd-5th fingers. AUSCAN, Australian/Canadian osteoarthritis hand index; CHFS, Cochin hand functional scale; HAQ, Health Assessment Questionnaire; NSAID, nonsteroidal anti-inflammatory drug; OA, osteoarthritis; VAS, visual analogue scale.
Quality ratings of included studies according to the PEDro methodology scoring system
| Study | Random assignment | Concealed allocation | Groups similar at baseline | Subject blind | Therapist blind | Assessor blind | <15% dropout | ITT analysis | Between-group analysis | Point measures | Score on PEDro scale |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rannou, | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | 8 |
| Basford, | Yes | No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | 8 |
| Brosseau, | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 10 |
| Stange-Rezende, | Yes | No | Yes | No | No | Yes | No | Yes | Yes | Yes | 6 |
| Favaro, | No | No | Yes | Yes | No | No | Yes | No | Yes | Yes | 5 |
| Stamm, | Yes | No | Yes | No | No | Yes | Yes | No | Yes | Yes | 6 |
| Lefler and Armstrong [ | Yes | No | Yes | No | No | No | Yes | No | Yes | Yes | 5 |
| Rogers and Wilder [ | Yes | No | Yes | Yes | No | No | No | No | Yes | No | 4 |
| Field, | Yes | No | No | No | No | No | No | No | Yes | Yes | 3 |
| Dickens and Lewith [ | Yes | Yes | No | No | No | Yes | Yes | No | Yes | Yes | 6 |
ITT, intention-to-treat; PEDro, Physiotherapy Evidence Database.
Treatment effects of rehabilitation interventions on study outcomes
| Outcome | Intervention | Study | Measurement tool | Number | SMD (95% CI) | Quality: score on PEDro scale |
|---|---|---|---|---|---|---|
| Pain | Splints | Rannou, | VAS | 101 | 0.19 (-0.20, 0.58) | 8 |
| Long-term | 97 | 4.24a (3.52, 4.97) | ||||
| Laser | Basford, | 0-5 tenderness | 81 | 0.00 (-0.44, 0.44) | 8 | |
| Brosseau, | AUSCAN pain | 86 | 0.33 (-0.10, 0.75) | 10 | ||
| Long-term | -0.88 (-0.5, 0.35) | |||||
| Heat therapy | Stange-Rezende, | VAS | 45 | 0.09 (-0.32, 0.05) | 6 | |
| Exercise | Lefler and Armstrong [ | 0-6 pain scale | 18 | 0.40 (-0.56, 1.36) | 5 | |
| Rogers and Wilder [ | AUSCAN pain | 46 | -0.04 (-0.45, 0.37) | 4 | ||
| Massage | Field, | VITAS | 22 | 1.18a (0.26, 2.10) | 3 | |
| Acupuncture | Dickens and Lewith [ | VAS | 13 | NA | 6 | |
| Hand function | Splints | Rannou, | CHFS | 101 | 1.10a (0.68, 1.52) | 8 |
| Long-term | 95 | 3.73a (3.05,4.40) | ||||
| Laser | Brosseau, | AUSCAN ADL | 86 | 0.08 (-0.34, 0.50) | 10 | |
| Long-term | -0.05 (-0.48, 0.37 | |||||
| Heat therapy | Stange-Rezende, | AUSCAN | 45 | 0.20 (-0.27, 0.67) | 6 | |
| Exercise | Stamm, | HAQ | 40 | NA | 6 | |
| Rogers and Wilder [ | AUSCAN ADL | 35 | -0.08 (-0.55,0.39) | 4 | ||
| Acupuncture | Dickens and Lewith [ | NS | 13 | NA | 6 | |
| Hand strength | Splints | Rannou, | Pinch (Dy) | 96 | 0.9a (0.5, 1.3) | 8 |
| Long-term | 1.2a (0.8, 1.6) | |||||
| Laser | Basford, | Grasp (Dy) | 81 | 0.01 (-0.4, 0.5) | 8 | |
| Brosseau, | Grip (Dy) | 86 | NA | 10 | ||
| Heat therapy | Stange-Rezende, | Grip (NS) | 45 | 0.00 (-0.4, 0.4) | 6 | |
| Favaro, | Grip (S) | 48 | NA | 5 | ||
| Exercise | Stamm, | Grip (V) | 40 | 4.5a (3.3, 5.7) | 6 | |
| Lefler and Armstrong [ | Grip (Dy) | 18 | 0.7 (-0.13, 1.7) | 5 | ||
| Rogers and Wilder [ | Grip (Dy) | 31 | 0.2 (-0.3, 0.7) | 4 | ||
| Massage | Field, | Grip -10-point scale | 22 | 0.9 (-0.01, 1.7) | 3 | |
| Acupuncture | Dickens and Lewith [ | Pinch (NS) | 13 | NA | 6 | |
| Range of motion | Splints | Rannou, | KI | 97 | -0.4a (-0.8, -0.03) | 8 |
| Long-term | 3.30a (2.7, 3.9) | |||||
| Laser | Basford, | Goniometer | 81 | 0.00 (-0.4, 0.5) | 8 | |
| Brosseau, | Goniometer | 86 | NA | 10 | ||
| Exercise | Lefler and Armstrong [ | Goniometer | 18 | NA | 5 | |
| Stiffness | Laser | Brosseau, | AUSCAN stiffness | 86 | 0.30 (-0.1, 0.7) | 10 |
| Long-term | -0.4 (-0.8, 0) | |||||
| Heat therapy | Stange-Rezende, | AUSCAN stiffness | 45 | -0.04 (-0.3, 0.2) | 6 | |
| Exercise | Rogers and Wilder [ | AUSCAN stiffness | 31 | 3.00 (-45, 51) | 4 |
aSignificant treatment effects. ADL, activities of daily living; AUSCAN, Australian/Canadian osteoarthritis hand index; CHFS, Cochin hand functional scale; CI, confidence intervals for continuous variables; Dy, dynamometer(s); HAQ, Health Assessment Questionnaire; KI, Kapandji index (thumb opposition); NA, standardized mean difference not estimable; NS, measurement tool not stated; PEDro, Physiotherapy Evidence Database; S, sphygmomanometer; SMD, standardized mean difference; V, vigorimeter; VAS, visual analogue scale; VITAS, visual analogue scale anchored with five faces.
Figure 2Treatment effects of the higher-quality studies on pain. CI, confidence interval; SMD, standardized mean difference.
Figure 3Treatment effects of the higher-quality studies on function. CI, confidence interval; SMD, standardized mean difference.
Figure 4Treatment effects of the higher-quality studies on strength. CI, confidence interval; SMD, standardized mean difference.
Figure 5Treatment effects of the higher-quality studies on range of motion (ROM). CI, confidence interval; SMD, standardized mean difference.
Figure 6Treatment effects of the higher-quality studies on stiffness. CI, confidence interval; SMD, standardized mean difference.
Summary of the higher-quality evidence for treating impairments and function in individuals with hand osteoarthritis
| Treatment goals | Joints | Intervention | LOE | Quality: score on PEDro scale | Outcome tool | SMD (95% CI) |
|---|---|---|---|---|---|---|
| Pain reduction | CMC + IP | Splints: long-term night use (>12 months) [ | 1b | 8 | VAS | 4.24 (3.52, 4.97) |
| Improve hand function | CMC + IP | Splints: Short-term night use (1 month) [ | 1b | 8 | CHFS | 1.10 (0.68, 1.52) |
| Splints: Long-term night use (>12 months) [ | 3.73 (3.05,4.40) | |||||
| CMC + IP | Joint protection education plus home exercise program [ | 2b | 6 | HAQ | NA, | |
| Improve hand strength | CMC + IP | Splints: Short-term night use (1 month) [ | 1b | 8 | Pinch (Dy) | 0.9 (0.5, 1.3) |
| Splints: Long-term night use (>12 months) [ | 1.2 (0.8, 1.6) | |||||
| CMC + IP | Joint protection education plus home exercise program [ | 2b | 6 | Grip (V) | 4.5 (3.3, 5.7) | |
| Improve range of motion | CMC + IP | Splints: Long-term night use (>12 months) [ | 1b | 8 | KI | 3.30 (2.7, 3.9) |
| CMC | Low-level laser (20 minutes/session × 3 sessions/week) [ | 1b | 10 | G | NA, | |
| Decrease stiffness | - | - | - | - | - | - |
CHFS, Cochin hand functional scale; CI, confidence intervals for continuous variables; CMC, carpometacarpal; Dy, dynamometer(s); G, goniometer (s); HAQ, Health Assessment Questionnaire; IP, interphalangeal; KI, Kapandji index (thumb opposition); LOE, level of evidence (Oxford); NA, standardized mean difference not estimable; PEDro, Physiotherapy Evidence Database; SMD, standardized mean difference; V, vigorimeter VAS, visual analogue scale.